• Explore /
  • Poster
  • / Nimotuzumab combined with cisplatin plus fluorouracil chemotherapy in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: A multicentre, open-label, phase II clinical trial.

Nimotuzumab combined with cisplatin plus fluorouracil chemotherapy in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: A multicentre, open-label, phase II clinical trial.

Abstract Poster

Authors

null

Chong Zhao

Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China

Chong Zhao , Jingjing Miao , Guanzhu Shen , Jin-Gao Li , Ning Zhang , Mei Shi , Lin Wang , Guoqing Hu , Xiaozhong Chen , Xuefeng Hu , Shi Xiu Wu , Jiaxin Chen , Xunfan Shao , Conghua Xie

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT01616849

Citation

J Clin Oncol 35, 2017 (suppl; abstr 6028)

DOI

10.1200/JCO.2017.35.15_suppl.6028

Abstract #

6028

Poster Bd #

16

Abstract Disclosures

Similar Posters

First Author: Gianluca Tomasello

First Author: Robert Lance Fine

First Author: Esma Kerboua

First Author: Markus Hermann Moehler